Our technologies

Biopharm

Imatinib and other ABL inhibitors to treat ocular neovascularisation

p { margin-top: 0px;margin-bottom: 12px;line-height: 1.15; } body { font-family: ‘Verdana';font-style: Normal;font-weight: normal;font-size: 16px; } .Normal { telerik-style-type: paragraph;telerik-style-name: Normal;border-collapse: collapse; } .TableNormal { telerik-style-type: table;telerik-style-name: TableNormal;border-collapse: collapse; } .Hyperlink { telerik-style-type: character;telerik-style-name: Hyperlink;color: #0000FF;text-decoration: underline;border-collapse: collapse; } Available for: Exclusive LicensingSummaryRetinal and choroidal diseases are the most common cause of vision loss in the

More info »

Biopharm

New lentiviral platform eliminating packaging sequences from the transcribed DNA region

p { margin-top: 0px;margin-bottom: 12px;line-height: 1.15; } body { font-family: ‘Verdana';font-style: Normal;font-weight: normal;font-size: 16px; } .Normal { telerik-style-type: paragraph;telerik-style-name: Normal;border-collapse: collapse; } .TableNormal { telerik-style-type: table;telerik-style-name: TableNormal;border-collapse: collapse; } .Hyperlink { telerik-style-type: character;telerik-style-name: Hyperlink;color: #0000FF;text-decoration: underline;border-collapse: collapse; } Available for: Exclusive/Non-exclusive LicensingSummaryAll lentiviral vectors described to date contain packaging sequences necessary for the viral RNA

More info »

Biopharm

Novel Therapy for Polycystic Kidney Disease (PKD)

p { margin-top: 0px;margin-bottom: 12px;line-height: 1.15; } body { font-family: ‘Verdana';font-style: Normal;font-weight: normal;font-size: 16px; } .Normal { telerik-style-type: paragraph;telerik-style-name: Normal;border-collapse: collapse; } .TableNormal { telerik-style-type: table;telerik-style-name: TableNormal;border-collapse: collapse; } .Hyperlink { telerik-style-type: character;telerik-style-name: Hyperlink;color: #0000FF;text-decoration: underline;border-collapse: collapse; } Available for: Exclusive/Non-Exclusive LicensingSummaryPolycystic kidney disease is the most common inherited cause of kidney failure, affecting 1

More info »

Biopharm

Silica Wool

Porous superhydrophobic/ superoleophillic material for oil-water separation and remediationAvailable for: Exclusive and Non-Exclusive LicensingSummaryThe technology comprises a porous material having both superhydrophobic and superoleophillic properties and is suitable for water-oil separation /filtration and remediation. Laboratory results achieved to date have used functionalised silica wool and have demonstrated high oil-water separation efficacy. The best performing solvent

More info »

Biopharm

H4R antagonists for uveitis and other inflammatory diseases

p { margin-top: 0px;margin-bottom: 12px;line-height: 1.15; } body { font-family: ‘Verdana';font-style: Normal;font-weight: normal;font-size: 16px; } .Normal { telerik-style-type: paragraph;telerik-style-name: Normal;border-collapse: collapse; } .TableNormal { telerik-style-type: table;telerik-style-name: TableNormal;border-collapse: collapse; } .Hyperlink { telerik-style-type: character;telerik-style-name: Hyperlink;color: #0000FF;text-decoration: underline;border-collapse: collapse; } Available For: Exclusive LicensingSummaryHistamine is a pleiotropic mediator involved in a variety of physiological processes including neurotransmission,

More info »

Biopharm

Modulating Sonic Hedgehog signalling for treatment of Autoimmune Disease and Inflammation

p { margin-top: 0px;margin-bottom: 12px;line-height: 1.15; } body { font-family: ‘Verdana';font-style: Normal;font-weight: normal;font-size: 16px; } .Normal { telerik-style-type: paragraph;telerik-style-name: Normal;border-collapse: collapse; } .TableNormal { telerik-style-type: table;telerik-style-name: TableNormal;border-collapse: collapse; } .Hyperlink { telerik-style-type: character;telerik-style-name: Hyperlink;color: #0000FF;text-decoration: underline;border-collapse: collapse; } Available for: Exclusive/Non-exclusive licensingSummaryChronic inflammation plays role in diseases such as asthma, atopic skin conditions and cancer.

More info »

Biopharm

Formulations for the Prevention of Neural Tube Defects

Formulations for the Prevention of Neural Tube DefectsAvailable for: LicenseSummaryExploring ways to prevent birth defects,researchers at the UCL Institute of Child Health have discovered novel supplements that if taken in pregnancy can reduce the chance of the baby having neural tube defects such as spina bifida or anencephaly. These are important in pregnancies where folic

More info »

Biopharm

New genetic marker for Age-related Macular Degeneration (AMD)

p { margin-top: 0px;margin-bottom: 0px;line-height: 1.15; } body { font-family: ‘Verdana';font-style: Normal;font-weight: normal;font-size: 16px; } .Normal { telerik-style-type: paragraph;telerik-style-name: Normal;border-collapse: collapse; } .TableNormal { telerik-style-type: table;telerik-style-name: TableNormal;border-collapse: collapse; } .Hyperlink { telerik-style-type: character;telerik-style-name: Hyperlink;color: #0000FF;text-decoration: underline;border-collapse: collapse; } Available for: Exclusive/Non-exclusive licensingSummaryAMD is the most common cause of irreversible vision impairment in the Western world

More info »

Biopharm

Dry Eye Diagnosis and Monitoring Software

p { margin-top: 0px;margin-bottom: 12px;line-height: 1.15; } body { font-family: ‘Verdana';font-style: Normal;font-weight: normal;font-size: 16px; } .Normal { telerik-style-type: paragraph;telerik-style-name: Normal;border-collapse: collapse; } .TableNormal { telerik-style-type: table;telerik-style-name: TableNormal;border-collapse: collapse; } .Hyperlink { telerik-style-type: character;telerik-style-name: Hyperlink;color: #0000FF;text-decoration: underline;border-collapse: collapse; } Available For: Exclusive/Non-Exclusive/OptionSummaryClinicians at Moorfields Eye Hospital, the leading provider of eye health services in Europe have

More info »

Physical Sciences

Non-Volatile Memory - Resistive Random Access Memory RRAM

Available for: Licensing and Joint DevelopmentSummaryResearch within the Department of Electronic and Electrical Engineering (E&EE) at UCL has led to the realisation of a new memory device, based on resistive switching which has the potential to be integrated directly onto silicon. The memory device exhibits very fast switching with high resistance contrast, requiring low switching

More info »

View by:

Technology area:
Theme:
Market:
Search: